NMTC Stock Analysis: Buy, Sell, or Hold?
NMTC - NeuroOne Medical Technologies Corporation Common Stock
$2.03
-0.12 (-5.58%)
âŧ
5d:
+4.64%
30d:
+9.73%
90d:
-47.95%
WAIT
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Aug 13, 2026
0d
Get Alerted When NMTC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: NMTC is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: NMTC is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: NMTC is currently trading at $2.03, which is considered slightly high relative to its 30-day fair value range of $1.61 to $2.17.
Technical Outlook: Technically, NMTC is in a downtrend. Immediate support is located at $1.46, while resistance sits at $2.37. Short-term momentum is weak, with the stock down 5.6% recently.
Market Sentiment: NMTC scores 10/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $7.27 (+258.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, NMTC is in a downtrend. Immediate support is located at $1.46, while resistance sits at $2.37. Short-term momentum is weak, with the stock down 5.6% recently.
Market Sentiment: NMTC scores 10/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $7.27 (+258.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$1.61 -
$2.17
Company Quality Score
38/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
36.8%
All Signals
- BEARISH: Weak technical setup (10/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-5.6%)
- BULLISH: Trading 258.0% below Wall St target ($7.27)
- WARNING: Composite score 38/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$1.61 -
$2.17
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$1.46
Resistance Level
$2.37
Current Trend
Downtrend
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-3.21
Wall Street Target
$7.27
(+258.0%)
Revenue Growth (YoY)
16.3%
Profit Margin
-59.7%
Share & Embed Analysis
Last updated: August 22, 2026 11:50 AM ET
Data refreshes hourly during market hours. Next update: 12:50 PM
Data refreshes hourly during market hours. Next update: 12:50 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NMTC showing a specific setup today?
Insider Activity (6 Months)
1
Buys
4
Sells
Net
INSIDERS SELLING
Recent Transactions
Mark Christianson
SELL
16 shares
2026-03-13
Mark Christianson
SELL
136 shares
2026-03-12
Mark Christianson
SELL
351 shares
2026-03-11
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$63 | 49 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$383 | 53 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$172 | 48 HOLD |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$101 | 49 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$98 | 35 SELL |
